STOCK TITAN

Cronos Group (CRON) Stock News

CRON Nasdaq

Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.

Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.

Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.

Rhea-AI Summary

Cronos Group, a global cannabinoid company, announced that its Executive Chairman, Mike Gorenstein, will speak at the CIBC 19th Annual Eastern Institutional Investor Conference on September 17, 2020, at 2:40 p.m. EDT. The conference will be accessible via a webcast on the Company's investor website. Cronos Group is focused on advancing cannabis research and developing an iconic brand portfolio, including wellness and adult-use brands. Their portfolio includes PEACE NATURALS™, COVE™, Spinach™, Lord Jones™, and PEACE+™.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
conferences
-
Rhea-AI Summary

Cronos Group has appointed Kurt Schmidt as President and CEO, effective September 9, 2020. Schmidt brings over 30 years of consumer packaged goods experience, having held key roles at Blue Buffalo and Nestlé. Mike Gorenstein transitions to Executive Chairman after serving as CEO since 2016. Both leaders aim to drive growth and leverage Cronos' strengths in cannabinoid innovation and brand development. The leadership change is expected to enhance company performance and accelerate its mission to create a strong brand portfolio and advanced cannabis research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none

FAQ

What is the current stock price of Cronos Group (CRON)?

The current stock price of Cronos Group (CRON) is $2.73 as of June 25, 2026.

What is the market cap of Cronos Group (CRON)?

The market cap of Cronos Group (CRON) is approximately 1.0B.